Publications by authors named "Ryoichi Maenosono"

Claim this Profile
C
Comparison of Oncological Outcomes of Conventional Androgen Deprivation Therapy (ADT) and ADT Plus Androgen Receptor Signaling Inhibitor in Older Patients With Metastatic Castration-Sensitive Prostate Cancer.
Yutaka Yamamoto, Saizo Fujimoto, Mamoru Hashimoto, Takafumi Minami, Wataru Fukuokaya, Ryoichi Maenosono

Int J Urol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of Cytoreductive Nephrectomy in the Immune Checkpoint Inhibitor Era: A Multicenter Collaborative Study.
Takuhisa Nukaya, Kiyoshi Takahara, Shingo Toyoda, Lan Inoki, Wataru Fukuokaya, Ryoichi Maenosono

Int J Urol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of early progressive disease and antitumor effects by metastatic site in renal cell carcinoma treated with ipilimumab plus nivolumab.
Keiichiro Mori, Takafumi Yanagisawa, Tatsushi Kawada, Satoshi Katayama, Ryoichi Maenosono

Int J Clin Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation Between First-line Immunotherapy and Second-line TKI Outcomes in Metastatic Renal Cell Carcinoma.
Koichi Sugimoto, Takafumi Minami, Takuhisa Nukaya, Ryoichi Maenosono, Takuya Tsujino

Cancer Diagn Progn· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discordance between PSA level and bone metastatic volume is associated with unfavourable prognosis.
Tomoki Shirafuji, Yasutaka Yamada, Kodai Sato, Zhao Xue, Takuya Tsujino, Ryoichi Maenosono

BJU Int· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Impact of Initial Prostate-Specific Antigen in Metastatic Hormone-Sensitive Prostate Cancer Patients With Extensive Bone Metastases Under Androgen Receptor Signaling Inhibitor.
Saizo Fujimoto, Tsuyoshi Morita, Yutaka Yamamoto, Masanobu Saruta, Atsuhiko Yoshizawa, Ryoichi Maenosono

Prostate· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world Outcomes of Enfortumab Vedotin in Elderly Patients With Metastatic Urothelial Carcinoma.
Kyosuke Nishio, Kensuke Hirosuna, Taizo Uchimoto, Heima Niigawa, Sho Kakumae, Ryoichi Maenosono

Anticancer Res· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of lung metastasis in patients treated with androgen receptor signaling inhibitors for castration-sensitive prostate cancer: data from the ULTRA-Japan Consortium.
Taizo Uchimoto, Kensuke Hirosuna, Heima Niigawa, Sho Kakumae, Hirofumi Morinaka, Ryoichi Maenosono

Jpn J Clin Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rash and Endocrine Disorders Predict Improved Survival in Metastatic Renal Cell Carcinoma Treated With Immunotherapy.
Koichi Sugimoto, Takafumi Minami, Shingo Toyoda, Lan Inoki, Takuhisa Nukaya, Ryoichi Maenosono

Anticancer Res· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Upper urinary tract urothelial carcinoma patients show better overall response rate than bladder cancer patients during enfortumab vedotin treatment following pembrolizumab.
Mamoru Hashimoto, Ken Fukiage, Kosei Taniguchi, Takafumi Minami, Wataru Fukuokaya, Ryoichi Maenosono

Transl Androl Urol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PRC2-mediated apoptosis evasion is a therapeutic target of MDS/AML harboring inv(3)/t(3;3) and monosomy 7.
Hiroyoshi Kunimoto, Ayaka Miura, Maiko Sagisaka, Mieko Ito, Ryoichi Maenosono

Hemasphere· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eosinophils as a predictive marker of treatment-related adverse events in mRCC patients treated with first-line immune-checkpoint inhibitor combination therapy.
Tatsushi Kawada, Satoshi Katayama, Takafumi Yanagisawa, Keiichiro Mori, Wataru Fukuokaya, Ryoichi Maenosono

Sci Rep· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of body mass index and tumor response in metastatic urothelial carcinoma treated with enfortumab vedotin: data from the ULTRA-Japan consortium.
Taizo Uchimoto, Kengo Iwatsuki, Kazumasa Komura, Wataru Fukuokaya, Takahiro Adachi, Ryoichi Maenosono

Int J Clin Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer-induced Pain Is Associated With Poor Overall Survival of Urothelial Carcinoma Patients Treated With Enfortumab Vedotin.
Mamoru Hashimoto, Ken Fukiage, Kosei Taniguchi, Takafumi Minami, Takafumi Yanagisawa, Ryoichi Maenosono

In Vivo· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual compartment utility of BRET-based biosensors for PPP2R5A/B56α, a cancer-associated B regulatory subunit of PP2A.
Hirofumi Yamauchi, Atsuro Oishi, Masahiko Ajiro, Atsuhito Nakayama, Kazuki Nishimura, Ryoichi Maenosono

Biotechniques· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of PSA dynamics and oncological outcomes in patients with metastatic hormone-sensitive prostate cancer treated with androgen receptor signaling inhibitors.
Yasutaka Yamada, Kodai Sato, Shinichi Sakamoto, Takuya Tsujino, Sinpei Saito, Ryoichi Maenosono

Int J Clin Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical significance of primary tumor progression in metastatic hormone-sensitive prostate cancer.
Yasutaka Yamada, Shinichi Sakamoto, Takuya Tsujino, Sinpei Saito, Kodai Sato, Ryoichi Maenosono

Prostate Int· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deciphering RCC immunotherapy outcomes: insights from a Japanese multi-institutional study on the CANLPH score's impact.
Tatsuo Fukushima, Takuya Tsujino, Moritoshi Sakamoto, Kiyoshi Takahara, Kazumasa Komura, Ryoichi Maenosono

World J Urol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting time to castration resistance with androgen-receptor signaling inhibitors in hormone-sensitive prostate cancer: data from ULTRA-Japan Consortium.
Taizo Uchimoto, Kengo Iwatsuki, Kazumasa Komura, Wataru Fukuokaya, Takahiro Adachi, Ryoichi Maenosono

Int J Clin Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes and prognostic factors in metastatic nonclear cell renal cell carcinoma treated with immuno-oncology combination therapy.
Shingo Toyoda, Wataru Fukuokaya, Keiichiro Mori, Tatsushi Kawada, Satoshi Katayama, Ryoichi Maenosono

Jpn J Clin Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanistic insights into lethal hyper progressive disease induced by PD-L1 inhibitor in metastatic urothelial carcinoma.
Kazuki Nishimura, Kiyoshi Takahara, Kazumasa Komura, Mitsuaki Ishida, Kensuke Hirosuna, Ryoichi Maenosono

NPJ Precis Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The medical cost and outcome of desensitization protocol in kidney transplantation recipients with high immunological risks.
Ryoichi Maenosono, Kohei Unagami, Rikako Oki, Yuya Fujiwara, Taro Banno

Int J Urol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nephron-sparing ureteroscopic surgery vs. radical nephroureterectomy: comparable survival-outcomes in upper tract urothelial carcinoma.
Takuya Tsujino, Kazumasa Komura, Teruo Inamoto, Ryoichi Maenosono, Takeshi Hashimoto

World J Urol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of FGFR3 Alterations on the Tumor Microenvironment and the Efficacy of Immune Checkpoint Inhibitors in Bladder Cancer.
Kazumasa Komura, Kensuke Hirosuna, Satoshi Tokushige, Takuya Tsujino, Kazuki Nishimura, Ryoichi Maenosono

Mol Cancer· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex difference and immunosenescence affect transplantation outcomes.
Ryoichi Maenosono

Front Transplant· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis